Portomesenteric thrombosis with bowel necrosis in COVID-19 patient: case report
Abstract
Background: COVID-19 related hypercoagulability is by now a well-established complication of this viral disease. The exact pathophysiological mechanisms of this process are not entirely clear but endothelial cell damage is thought to be a precursor to the pathological activation of the coagulation cascade. Although pulmonary embolism is the commonest thrombotic event, thromboemboli can form anywhere in the body and intraabdominal vessels are no exception. Descriptions of cases with bowel necrosis due to portomesenteric thrombosis have been increasingly emerging.
Case study: We present the case of a 60-year-old male COVID-19 positive patient with a radiologically confirmed portal vein and superior mesenteric vein thrombosis with small bowel necrosis treated surgically at our Institution. The thrombotic event was contributed to the viral infection and in conjunction with surgical treatment anticoagulant therapy was introduced.
Conclusion: Although often self limiting, gastrointestinal complaints in covid patients could also prove to be a surgical emergency. High risk of thromboembolic events in COVID-19 patients has to be taken into consideration while examining and treating the patient.
Downloads
Copyright (c) 2024 Acta Chirurgica Croatica
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby authorize the Acta Chirurgica Croatica (ACC) to publish their work.
The authors are aware that although ACC is Open Access journal, the copyright of all material published is vested in ACC. Open access articles are freely available to read, download, and share from the time of publication under the terms of the Creative Commons License Attribution ‐ NonCommerical No Derivative (CC BY‐NC‐ND) license. This license does not permit reuse for any commercial purposes nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission of ACC and appropriate acknowledgment of its source. The authors permit ACC to allow third parties to copy any part of the work without asking for permission, provided that the reference to the source is given and that this is not done for commercial purposes. Except for copyright, other proprietary rights related to the work (e.g., patent or other rights to any process or procedure) shall be retained by the author. To reproduce any text, figures, tables, or illustrations from this work in future works of their own, the author must obtain written permission from ACC.
Each of the author(s) hereby also grants permission to ACC to use such author’s name and likeness in connection with any past, present or future promotional activity by ACC, including, but not limited to, promotions for upcoming issues or publications, circulation solicitations, advertising or other publications in connection with ACC. Also, each of the author(s) hereby grants permission to ACC to use the manuscript in editorial research related to the improvement of editorial conduct, decision making, and issues related to peer review.
Each of the author(s) hereby releases and shall indemnify and hold harmless ACC and its successors, assigns, licensees, officers, directors, employees, and their respective heirs and representatives from and against any and all liabilities, losses, damages and expenses arising out of any claims of any kind that may be asserted against any of them based in whole or in part on any breach of the author(s)’ representations or warranties herein or in the work or anything contained in the work, including but not limited to any claims for copyright infringement or violation of any rights of privacy or publicity.
